Heesun J. Rogers

Hematology
2500 Metrohealth Dr
Cleveland, OH 44109

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications

Myeloid/lymphoid neoplasm with FLT3 gene fusion: report of a case with a novel t(5;13)(q13;q12) SSBP2::FLT3 fusion.

Myeloid/lymphoid neoplasm with FLT3 gene fusion: report of a case with a novel t(5;13)(q13;q12) SSBP2::FLT3 fusion.

Journal: Journal of hematopathology
Published: April 02, 2026

Multilineage lymphoid clonal hematopoiesis: a cross-sectional, correlative analysis of plasma cell dyscrasias and large granular lymphocytic leukemia.

Multilineage lymphoid clonal hematopoiesis: a cross-sectional, correlative analysis of plasma cell dyscrasias and large granular lymphocytic leukemia.

Journal: Leukemia
Published: March 24, 2026

Reply to "Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: a Bone Marrow Pathology Group study".

Reply to "Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: a Bone Marrow Pathology Group study".

Journal: American journal of clinical pathology
Published: September 20, 2024

Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia.

Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia.

Journal: Leukemia
Published: July 02, 2024

Clinical and molecular characteristics of extramedullary acute myeloid leukemias.

Clinical and molecular characteristics of extramedullary acute myeloid leukemias.

Journal: Leukemia
Published: May 16, 2024

Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study.

Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study.

Journal: American journal of clinical pathology
Published: December 12, 2023

Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting.

Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting.

Journal: Nature communications
Published: March 27, 2023

Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group.

Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group.

Journal: Leukemia & lymphoma
Published: March 24, 2023

Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology Group.

Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology Group.

Journal: Leukemia research
Published: March 14, 2023

Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group.

Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group.

Journal: JCO precision oncology
Published: January 23, 2023

The clinicopathologic significance of NPM1 mutation and ability to detect mutated NPM1 by immunohistochemistry in non-AML myeloid neoplasms.

The clinicopathologic significance of NPM1 mutation and ability to detect mutated NPM1 by immunohistochemistry in non-AML myeloid neoplasms.

Journal: Genes, chromosomes & cancer
Published: December 02, 2022

Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation.

Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation.

Journal: Leukemia research
Published: November 10, 2022
Showing 1-12 of 87

Last Updated: 09/26/2026